Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial.

CONCLUSIONS: The findings provide preliminary efficacy for a brief IE treatment for PTSD and point to the potential utility of MB for enhancing outcome. Brief interventions and better tailoring of MB augmentation strategies, adjusting for observed patterns, may have the potential to reduce dropout, accelerate change, and improve outcomes. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01188694. PMID: 28686823 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28686823?dopt=Abstract

Source: Journal of Clinical Psychiatry - July 9, 2017 Category: Psychiatry Tags: J Clin Psychiatry Source Type: research

More News: Learning | Post Traumatic Stress Disorder | Psychiatry | Training | Universities & Medical Training